APA (7th ed.) Citation

Bendstrup, E., Wuyts, W., Alfaro, T. M., Chaudhuri, N., Cornelissen, R., Kreuter, M., . . . Wijsenbeek, M. (2019). Nintedanib in idiopathic pulmonary fibrosis: Practical management recommendations for potential adverse events. Respiration, 97(2), . https://doi.org/10.1159/000495046

Chicago Style (17th ed.) Citation

Bendstrup, Elisabeth, et al. "Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events." Respiration 97, no. 2 (2019). https://doi.org/10.1159/000495046.

MLA (9th ed.) Citation

Bendstrup, Elisabeth, et al. "Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events." Respiration, vol. 97, no. 2, 2019, https://doi.org/10.1159/000495046.